Role of chemoreceptors in mediating dyspnea

https://doi.org/10.1016/j.resp.2008.12.002Get rights and content

Abstract

Dyspnea, or the uncomfortable awareness of respiratory distress, is a common symptom experienced by most people at some point during their lifetime. It is commonly encountered in individuals with pulmonary disease, such as chronic obstructive pulmonary disease (COPD), but can also be seen in healthy individuals after strenuous exercise, at altitude or in response to psychological stress. Dyspnea is a multifactorial sensation involving the brainstem, cortex, and limbic system, as well as mechanoreceptors, irritant receptors and chemoreceptors. Chemoreceptors appear to contribute to the sensation of dyspnea in two ways. They stimulate the respiratory control system in response to hypoxia and/or hypercapnia, and the resultant increase respiratory motor output can be consciously perceived as unpleasant. They also can induce the sensation of dyspnea through an as yet undetermined mechanism—potentially via direct ascending connections to the limbic system and cortex. The goal of this article is to briefly review how changes in blood gases reach conscious awareness and how chemoreceptors are involved in dyspnea.

Introduction

Dyspnea is the uncomfortable awareness of breathing, the sensation of breathlessness or the experience of air hunger (American Thoracic Society, 1999). It is an important clinical symptom used to assess functional status of chronically ill patients with cardiorespiratory or neuromuscular disease, and has thus been the subject of extensive recent reviews (Manning and Mahler, 2001, McConnell and Romer, 2004, O’Donnell et al., 2007). Healthy subjects can experience dyspnea during strenuous exercise, at high altitude, after breath-holding, or during stressful situations that cause anxiety or panic. Dyspnea occurs more frequently in the aged, the obese and the deconditioned. Certain medications can induce dyspnea as a side effect, and it is often the reason cited for cessation of a new medication or for medication non-compliance. It has been a difficult symptom to study, because it is a subjective and uniquely human experience so animal models have limited use in understanding its mechanisms, and it relies on often vague descriptions by patients (American Thoracic Society, 1999).

Dyspnea is a normal phenomenon that is protective against abnormalities in gas exchange. It can be caused by any number of derangements of normal cardiorespiratory function including primary pulmonary, cardiac or neuromuscular diseases. Pulmonary diseases include COPD, asthma, emphysema, interstitial lung disease, pulmonary edema, pulmonary embolism and pulmonary infections. Cardiac diseases include congestive heart failure and acute myocardial infarction (American Thoracic Society, 1999). Neurological diseases commonly leading to dyspnea include, but are not limited to, amyotrophic lateral sclerosis, myasthenia gravis, Guillain-Barré syndrome, multiple sclerosis and Parkinson's disease.

Awareness of respiratory sensation can occur in normal situations or during dyspnea. During dyspnea there is a heightened level of awareness of respiratory sensation and a strong emotional component. The neural basis of dyspnea is therefore likely to involve activation of both the cortex and the limbic system. As will be discussed below there is emerging evidence for cortical and limbic activation associated with dyspnea.

Dyspnea can be induced by an increase in CO2 or decrease in O2. There are several possibilities for how this occurs including direct effects from chemoreceptor activation or indirect effects either through interactions with other respiratory afferents or through activation of corollary discharges. There is evidence in the literature for each of these possibilities; however the specific mechanisms of the chemoreceptor contribution have not yet been elucidated. In order to understand how changes in blood gases cause dyspnea we need to understand how changes in O2 and CO2 are detected, how they influence breathing, and how these changes are transmitted to the forebrain.

Our goal with this review will be fourfold. First we will describe peripheral and central chemoreception and their contribution to the control of breathing. Second, we will describe the evidence that there can be conscious awareness of chemoreceptor input and that this input can induce the sensation of dyspnea. Third, we will speculate as to the mechanisms by which changes in blood gases reach consciousness and how they induce the sensation of dyspnea. Finally, we will discuss chemoreceptor contributions to dyspnea in certain human disease states.

Section snippets

Role of chemoreceptors in breathing

Chemoreceptors are instrumental in the regulation of breathing. Blood concentrations of O2 and CO2 as well as serum pH need to be maintained within a narrow range to ensure normal function of the body's tissues. Changes in the partial pressure of O2 (PO2) are sensed primarily by peripheral O2 chemoreceptors. Similarly, small changes in the partial pressure of CO2 (PCO2) are sensed primarily by central CO2 chemoreceptors. Activation of either chemoreceptor type leads to an increase in

Conscious awareness of blood gases and the role of chemoreceptors in dyspnea

It is well known that intense dyspnea can be induced by breathing a gas mixture with high CO2 or low O2 (American Thoracic Society, 1999). Hypercapnia-induced dyspnea is subjectively more intense than dyspnea induced by voluntary hyperventilation or exercise (Chonan et al., 1990). Dyspnea induced by hypercapnia could theoretically result either directly from activation of chemoreceptors, or indirectly by the increase in respiratory afferent feedback from the resulting increase in respiratory

Mechanisms leading to dyspnea in response to blood gas changes

In order to understand the mechanisms of dyspnea induced by hypercapnia we must define how chemoreceptor activation can directly or indirectly activate the forebrain.

Chemoreceptors and dyspnea in human disease

Chemoreceptors likely contribute to the sensation of dyspnea in normal, healthy individuals in some circumstances, but there are certain disease entities in which activation of chemoreceptors may be of particular relevance.

Summary

Dyspnea is a multifactorial sensation involving interplay of sensory afferent information onto the central respiratory control nuclei and connections to and from higher cortical and limbic centers (Fig. 5). Chemoreceptors certainly play a role in the sensation of dyspnea, likely via a combination of (1) increasing respiratory output and subsequent respiratory afferent activation, (2) activation of corollary discharges and (3) direct projections from chemoreceptors to forebrain

Acknowledgements

Supported by the NICHD, the VAMC, and the Bumpus Foundation.

References (151)

  • G.H. Dillon et al.

    In vitro responses of caudal hypothalamic neurons to hypoxia and hypercapnia

    Neuroscience

    (1992)
  • I.A. Dreshaj et al.

    Role of the medullary raphé nuclei in the respiratory response to CO2

    Respir. Physiol.

    (1998)
  • E. Edwards et al.

    Glutamate stimulation of raphé pallidus attenuates the cardiopulmonary reflex in anaesthetised rats

    Auton. Neurosci.

    (2000)
  • M.I. Fonseca et al.

    Distribution of serotonin 2A, 2C and 3 receptor mRNA in spinal cord and medulla oblongata

    Brain Res. Mol.

    (2001)
  • G.M. Halliday et al.

    Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease

    Brain Res.

    (1990)
  • C.J. Harmer

    Serotonin and emotional processing: does it help explain antidepressant drug action?

    Neuropharmacology

    (2008)
  • M.A. Haxhiu et al.

    Monoaminergic neurons, chemosensation and arousal

    Respir. Physiol.

    (2001)
  • M.A. Haxhiu et al.

    CO2-induced c-fos expression in the CNS catecholaminergic neurons

    Respir. Physiol.

    (1996)
  • J.G. Hensler

    Serotonergic modulation of the limbic system

    Neurosci. Biobehav. Rev.

    (2006)
  • R. Iturriaga et al.

    Neurotransmission in the carotid body: transmitters and modulators between glomus cells and petrosal ganglion nerve terminals

    Brain Res. Rev.

    (2004)
  • J.H. Jackson

    On asphyxia in slight epileptic paroxysms—on the symptomatology of slight epileptic fits supposed to depend on discharge-lesions of the uncinate gyrus

    Lancet

    (1899)
  • B.E. Jones et al.

    Ascending projections of the locus coeruleus in the rat. I. Axonal transport in central noradrenaline neurons

    Brain Res.

    (1977)
  • M.A. Katzman et al.

    Central and peripheral chemoreflexes in panic disorder

    Psychiatry Res.

    (2002)
  • T. Kuwaki et al.

    Emotional and state-dependent modification of cardiorespiratory function: role of orexinergic neurons

    Auton. Neurosci.

    (2008)
  • N. Larnicol et al.

    C-fos-like immunoreactivity in the cat's neuraxis following moderate hypoxia or hypercapnia

    J. Physiol. Paris

    (1994)
  • P.F. Martino et al.

    The cerebellar fastigial nucleus contributes to CO2-H+ ventilatory sensitivity in awake goats

    Respir. Physiol. Neurobiol.

    (2007)
  • M.L. Messier et al.

    Muscimol inhibition of medullary raphé neurons decreases the CO2 response and alters sleep in newborn piglets

    Respir. Physiol. Neurobiol.

    (2002)
  • R. Miles

    Does low pH stimulate central chemoreceptors located near the ventral medullary surface?

    Brain Res.

    (1983)
  • R. Mohan et al.

    The effect of hypoxia on the ventilatory response to carbon dioxide in man

    Respir. Physiol.

    (1997)
  • R.A. Mueller et al.

    Supersensitivity to the respiratory stimulatory effect of TRH in 5,7-dihydroxytryptamine-treated rats

    Brain Res.

    (1984)
  • T. Nambu et al.

    Distribution of orexin neurons in the adult rat brain

    Brain Res.

    (1999)
  • L. Adams et al.

    Breathlessness during different forms of ventilatory stimulation: a study of mechanisms in normal subjects and respiratory patients

    Clin. Sci. (Lond.)

    (1985)
  • Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society

    Am. J. Respir. Crit. Care Med.

    (1999)
  • E.E. Benarroch et al.

    Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy

    Brain

    (2007)
  • D.G. Bernard et al.

    Evidence for central chemoreception in the midline raphé

    J. Appl. Physiol.

    (1996)
  • M. Berthon-Jones et al.

    Ventilation and arousal responses to hypercapnia in normal sleeping humans

    J. Appl. Physiol.

    (1984)
  • P. Bouyer et al.

    Effect of extracellular acid-base disturbances on the intracellular pH of neurones cultured from rat medullary raphé or hippocampus

    J. Physiol.

    (2004)
  • H. Braak et al.

    Stages in the development of Parkinson's disease-related pathology

    Cell Tissue Res.

    (2004)
  • S.R. Bradley et al.

    Chemosensitive serotonergic neurons are closely associated with large medullary arteries

    Nat. Neurosci.

    (2002)
  • S. Brannan et al.

    Neuroimaging of cerebral activations and deactivations associated with hypercapnia and hunger for air

    Proc. Natl. Acad. Sci. U.S.A.

    (2001)
  • G.F. Buchanan et al.

    Deficiency in hypercapnia-induced arousal in mice with genetic deletion of 5-HT neurons

    Soc. Neurosci. Abstr.

    (2007)
  • G.F. Buchanan et al.

    Contribution of chemosensitive serotonergic neurons to interactions between the sleep-wake cycle and respiratory control

  • K.J. Buckler et al.

    Effects of hypercapnia on membrane potential and intracellular calcium in rat carotid body type I cells

    J. Physiol.

    (1994)
  • E.J. Campbell et al.

    The ability of man to detect added elastic loads to breathing

    Clin. Sci.

    (1961)
  • E.J. Campbell et al.

    The effect of muscular paralysis induced by tubocurarine on the duration and sensation of breath-holding

    Clin. Sci.

    (1967)
  • E.J. Campbell et al.

    The effect of muscular paralysis induced by tubocurarine on the duration and sensation of breath-holding during hypercapnia

    Clin. Sci.

    (1969)
  • R.J. Castele et al.

    Effects of changes in CO2 partial pressure on the sensation of respiratory drive

    J. Appl. Physiol.

    (1985)
  • Z. Chen et al.

    Respiratory-associated rhythmic firing of midbrain neurones in cats: relation to level of respiratory drive

    J. Physiol.

    (1991)
  • T. Chonan et al.

    Effects of voluntary constraining of thoracic displacement during hypercapnia

    J. Appl. Physiol.

    (1987)
  • T. Chonan et al.

    Sensation of dyspnea during hypercapnia, exercise, and voluntary hyperventilation

    J. Appl. Physiol.

    (1990)
  • Cited by (0)

    View full text